BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1146602)

  • 21. Vascular reactivity of rats after prevention of hypertension by central administration of 6-hydroxydopamine.
    Haeusler G
    J Hypertens Suppl; 1984 Dec; 2(3):S73-5. PubMed ID: 6443713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats.
    Hahn RA; Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1983 Jul; 226(1):39-45. PubMed ID: 6864549
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypotensive effect of clonidine and regional noradrenaline concentration in the brain of normotensive and hypertensive rats after acute and long-term treatment.
    Filczewski M; Szymańska-Kosmala M; Oledzka K; Bogucka E
    Acta Physiol Pol; 1981; 32(6):747-53. PubMed ID: 7348526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine.
    Finch L; Haeusler G; Kuhn H; Thoenen H
    Br J Pharmacol; 1972 Feb; 44(2):357P-358P. PubMed ID: 4668621
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurotensin-induced myocardial noradrenergic effects in spontaneously hypertensive rats.
    Osadchii O; Woodiwiss A; Deftereos D; Norton G
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):221-7. PubMed ID: 16495759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 4-(3-indolyl-alkyl) piperidine derivatives on brain 5-hydroxytryptamine turnover and on cardiac and brain noradrenaline or 5-hydroxytryptamine depletion induced by 6-hydroxydopamine, H 75/12 and 4-chloroamphetamine.
    Le Fur G; Mitrani N; Uzan A
    Biochem Pharmacol; 1977 Mar; 26(6):505-9. PubMed ID: 849347
    [No Abstract]   [Full Text] [Related]  

  • 27. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of 2-and/or 5-methylated analogues of 6-hydroxydopamine on norepinephrine-and dopamine-containing neurons.
    Liang YO; Adams RN
    Mol Pharmacol; 1977 Sep; 13(5):805-18. PubMed ID: 895717
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of mestranol on blood pressure and norepinephrine in young normotensive and genetically hypertensive rats.
    Lew GM
    Gen Pharmacol; 1978; 9(3):163-6. PubMed ID: 669247
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of prolonged treatment hypertensive rats with antihypertensive agents with different mechanisms of action on blood pressure and noradrenaline concentration in the myocardium, brain and aorta].
    Kiriakov A; Khlebarova M; Staneva-Stoicheva D; Panova I
    Eksp Med Morfol; 1973; 12(3):135-41. PubMed ID: 4806527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of hypertension in the SH rat: effects of differential central catecholamine depletion.
    Erinoff L; Heller A; Oparil S
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):748-54. PubMed ID: 1208597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The uptake and metabolism of noradrenaline in the isolated heart of spontaneously hypertensive rat.
    Nykänen PT; Ahtee L; Himberg JJ; Paasonen MK
    Pharmacology; 1973; 9(6):367-73. PubMed ID: 4746892
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenaline, noradrenaline and dopamine levels in brain and heart after administration of 6-hydroxydopamine and guanethedine to newborn mice.
    Liuzzi A; Foppen FH; Angeletti PU
    Biochem Pharmacol; 1974 Mar; 23(6):1041-4. PubMed ID: 4824904
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin levels in vascular tissue and the effects of a serotonin synthesis inhibitor on blood pressure in hypertensive rats.
    Jarrott B; McQueen A; Graf L; Louis WJ
    Clin Exp Pharmacol Physiol; 1975; Suppl 2():201-5. PubMed ID: 126833
    [No Abstract]   [Full Text] [Related]  

  • 35. Neonatal 6-hydroxydopamine sympathectomy in normotensive and spontaneously hypertensive rat.
    Pappas BA; Peters DA; Saari M; Sobrian SK; Minch E
    Pharmacol Biochem Behav; 1974 May; 2(3):381-6. PubMed ID: 4152115
    [No Abstract]   [Full Text] [Related]  

  • 36. Central catecholamine and peripheral noradrenaline depletion by 6-hydroxydopamine and active avoidance learning in rats.
    Oei TP; King MG
    J Comp Physiol Psychol; 1978 Feb; 92(1):94-108. PubMed ID: 627641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.
    Clark DW; Laverty R; Phelan EL
    Br J Pharmacol; 1972 Feb; 44(2):233-43. PubMed ID: 4677508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onset of hypertension in spontaneously hypertensive rats despite the depletion of spinal cord catecholamines.
    Loewy AD; McKellar S; Swensson EE; Panneton WM
    Brain Res; 1980 Mar; 185(2):449-54. PubMed ID: 7357439
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of high salt diet on cardiac 5-hydroxytryptamine in 6-hydroxydopamine treated rats.
    Weil-Fugazza J; Godefroy F
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):139-47. PubMed ID: 4824888
    [No Abstract]   [Full Text] [Related]  

  • 40. Depletion of brain norepinephrine by intraventricular injection of 6-hydroxydopa: a biochemical, histochemical and behavioral study in rats.
    Richardson JS; Jacobowitz DM
    Brain Res; 1973 Aug; 58(1):117-33. PubMed ID: 4740976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.